Pending

Lycium barbarum Polysaccharide Ameliorates Sjogren’s Syndrome in a Murine Model
Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjogren’s syndrome
Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib
Effectiveness and Safety of Iguratimod in Treating Primary Sjogren’s Syndrome: A Systematic Review and Meta-Analysis
Formation of Autoimmune Lesions Is Independent of Antibiotic Treatment in NOD Mice
Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial” by de Wolff et al
The Enduring Experience in Dry Eye Diagnosis: A Non-Interventional Study Comparing the Experiences of Patients Living With and Without Sjogren’s Syndrome
Atypical Sjogren’s Syndrome Initially Presenting as Lymphocytic Interstitial Pneumonitis followed by Immune Thrombocytopenia
Sjogren’s Syndrome and Pulmonary Disease
Rabbit models of dry eye disease: Current understanding and unmet needs for translational research
Mesenchymal stromal cells for the treatment of ocular autoimmune diseases
Activation of Toll-Like Receptor 7 Signaling Pathway in Primary Sjogren’s Syndrome-Associated Thrombocytopenia
Glomerulonephritis with severe nephrotic syndrome induced by immune complexes composed of galactose-deficient IgA1 in primary Sjogren’s syndrome: a case report
Coexistence of Sjogren syndrome in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A retrospective observational study
Evaluation of Asymptomatic Bacteriuria and Urinary Tract Infection in Patients With Primary Sjogren’s Syndrome
Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised controlled trial’
Pathology of salivary gland dysfunction and restoration of function
S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-alpha) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases
Secreted factors from dental pulp stem cells improve Sjogren’s syndrome via regulatory T cell-mediated immunosuppression
Muscle Tone Assessment under General Anesthesia for Sjogren-Larsson Syndrome and Spasticity
Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system
The relationship between Sjogren’s syndrome, systemic sclerosis and lymphoproliferative diseases
Juvenile primary Sjogren’s syndrome with cutaneous involvement
Salivary dysbiosis in Sjogren’s syndrome and a commensal-mediated immunomodulatory effect of salivary gland epithelial cells
Reactivity of human labial glands in response to cevimeline treatment
A Novel Approach for Immediate Implant-based Oral Rehabilitation in a Sjogren’s Syndrome Patient Using Virtual Surgical and Prosthetic Planning
Sjogren’s syndrome: from diagnosis to treatment
MTH1 inhibitors for the treatment of psoriasis
Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjogren’s Syndrome Model Mice
What is the evidence that mycobacteria are associated with the pathogenesis of Sjogren’s syndrome?
Not all Sicca is Sjogren’s and not all Sjogren’s is Sicca
Dental pulp-derived stem cell-conditioned media attenuates secondary Sjogren’s syndrome via suppression of inflammatory cytokines in the submandibular glands
Severe pulmonary arterial hypertension and massive ascites in a patient with systemic lupus erythematosus and secondary Sjogren’s syndrome
Deciphering potential pharmacological mechanism of Sha-Shen-Mai-Dong decoction on primary Sjogren’s syndrome
Two shared immune cell signatures stratify patients with Sjogren’s syndrome and systemic lupus erythematosus with potential therapeutic implications
Effects of cyclophosphamide and rituximab in patients with connective tissue diseases with severe interstitial lung disease
Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis
Transduction of Salivary Gland Acinar Cells with a Novel AAV Vector 44.9
The Impact of SARS-CoV-2 Outbreak on Primary Sjogren’s Syndrome: An Italian Experience
Primary Sjogren’s syndrome manifesting as sclerotic metabolic bone disease
Analysis of non-tuberculous mycobacterial lung disease in patients with primary Sjogren’s syndrome at a referral center
Lymphocyte subpopulations in Sjogren’s syndrome are distinct in anti-SSA-positive patients and related to disease activity
MicroRNA-146a-5p enhances T helper 17 cell differentiation via decreasing a disintegrin and metalloprotease 17 level in primary sjogren’s syndrome
Primary Sjogren syndrome increases the risk of bisphosphonate-related osteonecrosis of the jaw
Ocular Cicatricial Pemphigoid: Methotrexate as an Initial Treatment?
Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy
Immune Monitoring upon Treatment with Biologics in Sjogren’s Syndrome: The What, Where, When, and How
Lacrimal gland atrophy and dry eye related to isotretinoin, androgen, and prolactin: differential diagnosis for Sjogren’s syndrome
Neonatal lupus erythematosus – practical guidelines
Correction: Abughanam, G., et al. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren’s Syndrome-Like Disease. Int. J. Mol. Sci. 2019, 20, 4750
New frontiers in precision medicine for Sjogren’s syndrome
Interleukin 1alpha: a comprehensive review on the role of IL-1alpha in the pathogenesis and treatment of autoimmune and inflammatory diseases
Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren’s syndrome versus non-Sjogren’s syndrome
Systemic diseases and the cornea
Transcriptomic and Network Analysis of Minor Salivary Glands of Patients With Primary Sjogren’s Syndrome
A Case of Repeated TAFRO Syndrome-Like Symptoms and Retroperitoneal Hemorrhage in a Patient With Sjogren Syndrome
Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial” by Wang et al
Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial’
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
Asymptomatic Lymphocytic Interstitial Pneumonia with Extensive HRCT Changes Preceding Sjogren’s Syndrome
Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren’s syndrome: A review
Normal salivary gland ultrasonography could rule out the diagnosis of Sjogren’s syndrome in anti-SSA-negative patients with sicca syndrome
Knockdown of RSAD2 attenuates B cell hyperactivity in patients with primary Sjogren’s syndrome (pSS) via suppressing NF-kappab signaling pathway
Refractory IgG4-related Pleural Disease with Chylothorax: A Case Report and Literature Review
Mild stimulatory effect of a probiotic mix on bone mass when treatment is initiated 1.5 weeks after ovariectomy in mice
Evaluation of the effect of topical tacrolimus 0.03% versus cyclosporine 0.05% in the treatment of dry eye secondary to Sjogren syndrome
CD8(+) T Lymphocytes: Crucial Players in Sjogren’s Syndrome
Association between nucleos(t)ide analogue therapy for hepatitis B and Sjogren’s syndrome: 15-year analysis of the national database of Taiwan
Role of the HSP70 Co-Chaperone SIL1 in Health and Disease
Allogeneic and autologous serum eye drops: a pilot double-blind randomized crossover trial
SS-A52 antigen expression in thymic carcinoma accompanied with Sjogren syndrome: A case report
P2Y(2) receptor antagonism resolves sialadenitis and improves salivary flow in a Sjogren’s syndrome mouse model
Correction to: Treatment of acute Achilles tendon rupture – a multicentre, non-inferiority analysis
A Case of Immune-Mediated Necrotizing Myopathy Associated with Primary Sjogren Syndrome
A case report of Mikulicz’s disease
The Role of Interferons in the Pathogenesis of Sjogren’s Syndrome and Future Therapeutic Perspectives
Ocular Cicatricial Pemphigoid, Sjogren’s Syndrome, and Hashimoto’s Thyroiditis as a Multiple Autoimmune Syndrome: A case report
EULAR Sjögren’s syndrome study group: an eSSential way to address the unmet needs of the disease.
Neonatal lupus presenting as a non-specific rash in primary care.
Ocular Cicatricial Pemphigoid, Sjögren’s Syndrome, and Hashimoto’s Thyroiditis as a Multiple Autoimmune Syndrome: A case report.
Differences in clinical features between small fiber and sensitive large fiber neuropathies in Sjögren’s syndrome.
CD8+ T Lymphocytes: Crucial Players in Sjögren’s Syndrome.
Primary Sjogren’s syndrome manifesting with distal renal tubular acidosis and severe metabolic bone disease.
The Role of Interferons in the Pathogenesis of Sjögren’s Syndrome and Future Therapeutic Perspectives.
Epidemiology of Non-Hodgkin’s Lymphoma.
Neonatal lupus erythematosus presenting with rash, thrombocytopenia compounded by cytomegalovirus colonisation: a diagnostic dilemma.
[A Case of Immune-Mediated Necrotizing Myopathy Associated with Primary Sjögren Syndrome].
Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren’s syndrome patients: case series study and review of the literature.
Prevalence and clinical presentation of lymphoproliferative disorder in patients with primary Sjögren’s syndrome.
P2Y2 receptor antagonism resolves sialadenitis and improves salivary flow in a Sjögren’s syndrome mouse model.
Association between nucleos(t)ide analogue therapy for hepatitis B and Sjögren’s syndrome: 15-year analysis of the national database of Taiwan.
Vagus nerve stimulation in musculoskeletal diseases.
Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases.
Sicca syndrome following immune checkpoint inhibition.
Hydroxychloroquine in systemic and auto-immune diseases: where are we now?
Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren’s syndrome: A review.
Knockdown of RSAD2 attenuates B cell hyperactivity in patients with primary Sjögren’s syndrome (pSS) via suppressing NF-κb signaling pathway.
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications.

Asymptomatic Lymphocytic Interstitial Pneumonia with Extensive HRCT Changes Preceding Sjogren’s Syndrome.
Characteristics of diffuse large B-cell lymphoma in patients with primary Sjögren’s syndrome.
Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial” by Wang et al.
Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial’.
COVID-19 in Italian Sjögren’s syndrome patients: a monocentric study.
Transcriptomic and Network Analysis of Minor Salivary Glands of Patients With Primary Sjögren’s Syndrome.
Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren’s syndrome versus non-Sjogren’s syndrome.
Correction: Abughanam, G., et al. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren’s Syndrome-Like Disease. Int. J. Mol. Sci. 2019, 20, 4750.
A patient with primary Sjogren’s syndrome, cystic lung disease, and MALT lymphoma treated successfully with rituximab: a case-based review.
Immune Monitoring upon Treatment with Biologics in Sjögren’s Syndrome: The What, Where, When, and How.
Lacrimal gland atrophy and dry eye related to isotretinoin, androgen, and prolactin: differential diagnosis for Sjögren’s syndrome.
Neonatal lupus erythematosus – practical guidelines.
Mechanism of cAMP-PKA Signaling Pathway Mediated by Shaoyao Gancao Decoction () on Regulation of Aquaporin 5 and Muscarinic Receptor 3 Levels in Sjögren’s Syndrome.
Clinical characteristics of systemic lupus erythematosus with chylothorax and/or chylous ascites: An analysis of 15 cases in China.
Subacute cutaneous lupus erythematosus in a patient with Sjögren’s syndrome taking terbinafine for onychomycosis.
Ocular Cicatricial Pemphigoid: Methotrexate as an Initial Treatment?
Why is a paediatric respiratory specialist integral to the paediatric rheumatology clinic?
MicroRNA-146a-5p enhances T helper 17 cell differentiation via decreasing a disintegrin and metalloprotease 17 level in primary sjögren’s syndrome.
Lymphocyte subpopulations in Sjögren’s syndrome are distinct in anti-SSA-positive patients and related to disease activity.
Analysis of non-tuberculous mycobacterial lung disease in patients with primary Sjögren’s syndrome at a referral center.
Primary Sjögren’s syndrome manifesting as sclerotic metabolic bone disease.
The Impact of SARS-CoV-2 Outbreak on Primary Sjögren’s Syndrome: An Italian Experience.
Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies.
Suppression of high-mobility group box 1 ameliorates xerostomia in a Sjögren syndrome-triggered mouse model.
Mesenchymal Stem Cell Enhances the Function of MDSCs in Experimental Sjögren Syndrome.
[CAI Sheng-chao’s experience in treatment of Sjögren’s syndrome with moxibustion for promoting meridian circulation and warming yang].
Interleukin-22 and connective tissue diseases: emerging role in pathogenesis and therapy.
Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.
Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren’s syndrome by modulating the function of myeloid-derived suppressor cells.
Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis.
Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren’s syndrome or systemic lupus erythematosus.
Haematologic Indices And Disease Activity Index In Primary Sjogren’s Syndrome.
[Change of diagnosis and diagnostic category in patients with juvenile idiopathic arthritis within 7 years of follow-up].
B7-H3: A promising therapeutic target for autoimmune diseases.
Alleviating effect of paeoniflorin-6′-O-benzene sulfonate in antigen-induced experimental Sjögren’s syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK/p38 signaling pathway.
High-Fat Diet-Induced Functional and Pathologic Changes in Lacrimal Gland.
New developments in esophageal function testing and esophageal manifestations of connective tissue disorders.
Intralacrimal Sustained Delivery of Rapamycin Shows Therapeutic Effects without Systemic Toxicity in a Mouse Model of Autoimmune Dacryoadenitis Characteristic of Sjögren’s Syndrome.
Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.
Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment.
Renal Disease in Primary Sjögren’s Syndrome.
Systematic review of safety and efficacy of belimumab in treating immune-mediated disorders.
What’s new in ocular and oral aspects of Sjögren’s syndrome and do new treatments work?
Association of salivary inflammatory biomarkers with primary Sjögren’s syndrome.
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis.
Transcranial Direct Current Stimulation for Fatigue in Patients with Sjogren’s Syndrome: a Randomized, Double-blind Pilot Study.
Association Between Early Sjögren Markers and Symptoms and Signs of Dry Eye.
Community-acquired Klebsiella pneumoniae central nervous system infection after acute suppurative otitis.
Salivary Glands and Periodontal Changes in a Population of Sjögren’s and Sicca Syndrome Treated by Pilocarpine: A Pilot Study.
Targeted therapies in interstitial lung disease secondary to systemic autoimmune rheumatic disease. Current status and future development.
Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sjögren’s syndrome.
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus.
Environmental factors in the pathogenesis of primary Sjögren’s syndrome.
Proximal Muscle Weakness With Overlying Hypokalemic Periodic Paralysis in Sjögren Syndrome: Report of 6 Cases.
Primary Sjögren’s Syndrome and Cardiovascular Disease.
The impact of primary Sjogren’s syndrome on female sexual function.
Salivary Gland Mucosa-Associated Lymphoid Tissue-Type Lymphoma From Sjögren’s Syndrome Patients in the Majority Express Rheumatoid Factors Affinity-Selected for IgG.
Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?
Early diagnosis and treatment for Sjögren’s syndrome: current challenges, redefined disease stages and future prospects.
Sjögren’s Syndrome Associated With Thrombotic Thrombocytopenic Purpura: A Case-Based Review.
A Presentation of Pediatric Sjögren’s Syndrome with Abducens Nerve Palsy.
[Primary diffuse large B-cell lymphoma of the breast in a male patient with Sjögren’s syndrome].
Transduction of Salivary Gland Acinar Cells with a Novel AAV Vector 44.9.
Idiopathic multicentric Castleman disease with Sjögren’s syndrome and secondary membranous nephropathy: a case report and review of the literature.
Innate Immunity and Biological Therapies for the Treatment of Sjögren’s Syndrome.
Secretome Analysis of Inductive Signals for BM-MSC Transdifferentiation into Salivary Gland Progenitors.
Clinical features and outcomes from the Singapore Sjögren’s syndrome study.
Increased expression of interleukin-21-inducible genes in minor salivary glands are associated with primary Sjögren’s syndrome disease characteristics.
Releasing the brakes: a case report of pulmonary arterial hypertension induced by immune checkpoint inhibitor therapy.
Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia.
Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review.
Sjögren’s syndrome with rapidly progressive motor neuron disease: a case report.
The Prevalence of Sjögren’s Syndrome in Rheumatoid Arthritis Patients and Their Clinical Features.
Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren’s syndrome-associated dry eyes.
Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus.
Inhibition of bone morphogenetic protein 6 receptors ameliorates Sjögren’s syndrome in mice.
Ganglionic Acetylcholine Receptor Antibodies and Autonomic Dysfunction in Autoimmune Rheumatic Diseases.
Recurrent optic neuritis in a patient with Sjogren syndrome and neuromyelitis optica spectrum disorder: A case report.
[Renal involvement in Sjögren’s syndrome].
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.
A Case of Prolonged Catatonia Caused by Sjögren’s Syndrome.
Allergic diseases and long-term risk of autoimmune disorders: longitudinal cohort study and cluster analysis.
Chemosensory dysfunction, Oral disorders and Oral health-related quality of life in patients with primary Sjögren’s syndrome: comparative cross-sectional study.
Sirolimus for patients with connective tissue disease-related refractory thrombocytopenia: a single-arm, open-label clinical trial.
Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically Based Pharmacokinetic Modeling.
Successful Treatment of Urticarial Vasculitis in a Patient With Systemic Lupus Erythematosus With Rituximab.
Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases.
T Cells Subsets in the Immunopathology and Treatment of Sjogren’s Syndrome.
Effects of Anti-Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases.
Risk factors of attacks in neuromyelitis optica spectrum disorders.
Tracheobronchial amyloidosis in primary Sjögren syndrome: A case report.
Efficacy and safety of abatacept in active primary Sjögren’s syndrome: results of a phase III, randomised, placebo-controlled trial.
[Dry mouth. Case histories from a saliva clinic].
Interferon-stimulated GTPases in autoimmune and inflammatory diseases: promising role for the guanylate-binding protein (GBP) family.
Unusual Presentation of Polyautoimmunity and Renal Tubular Acidosis in an Adolescent With Hashimoto’s Thyroiditis and Central Pontine Myelinolysis.
Cytokines and Fatigue in Sjogren’s Syndrome: An Evolving Landscape.
Office-based salivary gland ductal irrigation in patients with chronic sialoadenitis: A preliminary study.
Sjögren syndrome associated with protein-losing enteropathy: case-based review.
Burden of illness among subgroups of patients with primary Sjögren’s syndrome and systemic involvement.
Catalpol ameliorates Sjögren’s Syndrome by modulating interplay of T and B cells.

Sialendoscopy and Sjogren’s Disease: A Systematic Review.
Neuromyelitis optica spectrum disorder complicated with Sjögren’s syndrome: first pediatric case responsive to mycophenolate mofetil treatment.
Cardiovascular Protection of Hydroxychloroquine in Patients with Sjögren’s Syndrome.
Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis.
Identification of Long Noncoding RNAs lnc-DC in Plasma as a New Biomarker for Primary Sjögren’s Syndrome.
Variability of salivary metabolite levels in patients with Sjögren’s syndrome.
Efficacy and safety of iguratimod on patients with primary Sjögren’s syndrome: a randomized, placebo-controlled clinical trial.
Composite Epstein-Barr virus-positive mucosa-associated lymphoid tissue lymphoma and Epstein-Barr virus-negative diffuse large B-cell lymphoma in the parotid salivary gland of a patient with Sjögren’s syndrome and rheumatoid arthritis: a case report.
Serious infections in Sjögren’s syndrome patients: a national U.S. study.
Type-III interferons in Sjögren’s syndrome.
A Training Tool to support the management and diagnosis of Sjögren’s syndrome.
One year in review 2020: pathogenesis of primary Sjögren’s syndrome.
Ianalumab (VAY736) in primary Sjögren’s syndrome: assessing disease activity using multi-modal ultrasound.
Pathogenesis of primary Sjögren’s syndrome beyond B lymphocytes.
Mediterranean diet and risk of Sjögren’s syndrome.
Biologic therapy in Sjögren’s syndrome.
Evaluation of lymphocytic infiltration in the bronchial glands of Sjögren’s syndrome in transbronchial lung cryobiopsy.
A Fast and Clean BTK Inhibitor.
Treatment of primary sjögren’s syndrome-related interstitial lung disease: a retrospective cohort study.
Clinically significant renal involvement in primary Sjögren’s syndrome is associated with important morbidity: data from the Spanish Sjögrenser cohort.
What about glucocorticoids in primary Sjögren’s syndrome?
Interstitial lung disease in Sjögren’s syndrome: a clinical review.
Blocking T cell co-stimulation in primary Sjögren’s syndrome: rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers.
Primary Sjögren’s syndrome: central and peripheral nervous system involvements.
Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren’s Syndrome.
A case report, a case who developed limited cutaneous scleroderma and pulmonary hypertension 8 years after diagnosis of anti-centromere antibody-positive Sjögren syndrome.
Distal Renal Tubular Acidosis in Sjögren’s Syndrome: A Case Report.
Fitness for purpose of routinely recorded health data to identify patients with complex diseases: The case of Sjögren’s syndrome.
Reduced salivary flow and caries status are correlated with disease activity and severity in patients with diffuse cutaneous systemic sclerosis.
Artesunate inhibits Sjögren’s syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
Pulmonary Manifestations of Primary Sjögren’s Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management.
Small trial with short duration does not provide evidence that probiotics reduce the risk of developing oral candidiasis in patients with Sjögren syndrome.
Development and exacerbation of pulmonary nontuberculous mycobacterial infection in patients with systemic autoimmune rheumatic diseases.
Interleukin-7/Interferon axis drives T-cell and salivary gland epithelial cell interactions in Sjögren’s syndrome.
Fingolimod reduces salivary infiltrates and increases salivary secretion in a murine Sjögren’s model.
Mycophenolate for the Treatment of Primary Sjögren’s Syndrome.
B7-H4 Inhibits the Development of Primary Sjögren’s Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice.
Takotsubo syndrome and rheumatic diseases-a critical systematic review.
Cytokine profiles and clinical characteristics in primary Sjögren´s syndrome patient groups.
Pilocarpine for Sjögren’s Syndrome-Induced Dry Mouth and Dry Eyes: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
Pilocarpine for Radiotherapy-Induced Dry Mouth and Dry Eyes: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
Clinical profile and associated factors of pulmonary involvement in primary Sjögren’s syndrome.
[Analysis of clinical features and prognosis in patients with primary Sjögren’s syndrome and autoimmune liver disease].
[Nasal manifestations of Sjogren’s syndrome].
Biomarkers and Diagnostic Testing for Renal Disease in Sjogren’s Syndrome.
Stem cell treatments for oropharyngeal dysphagia: Rationale, benefits, and challenges.
Checkpoint inhibition-induced sicca: a type II interferonopathy?
Comorbidity and health care utilisation in persons with Sjögren’s syndrome: a claims data analysis.
Compromised ultrasound remission, functional ability and clinical decision associated with overlapping Sjögren’s syndrome in rheumatoid arthritis patients: results from a propensity-score matched cohort from 2009 to 2019.
Characterisation of articular manifestations in primary Sjögren’s syndrome: clinical and imaging features.
T cell lymphoma in the setting of Sjögren’s syndrome: T cells gone bad? Report of five cases from a single centre cohort.
Primary Sjögren’s Syndrome Accompanied by Clinical Features of TAFRO Syndrome.
Comparison of Rituximab Originator With CT-P10 Biosimilar in Patients With Primary Sjögren’s Syndrome: A Retrospective Analysis in a Real-Life Setting.
sPLA2-IIa participates in ocular surface inflammation in humans with dry eye disease.
[Immune disorders associated with juvenile recurrent chronic parotitis].
Clinical phenotyping of primary Sjögren’s patients using salivary gland ultrasonography – data from the RESULT cohort.
Innate immune response in systemic autoimmune diseases: a potential target of therapy.
Intraoperative visualisation and treatment of salivary glands in Sjögren’s syndrome by contrast-enhanced ultrasound sialendoscopy (CEUSS): protocol for a phase I single-centre, single-arm, exploratory study.
Biologics in the treatment of Sjogren’s syndrome, systemic lupus erythematosus, and lupus nephritis.
Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases.
Myasthenia Gravis Coexisting With Primary Sjögren’s Syndrome: Report of Three Cases and Literature Review.
Bipolar Disorder as Comorbidity with Sjögren’s Syndrome: What Can We Do?
Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
Recurrent breast amyloidosis associated with Sjögren’s syndrome: A case report with description of the radiologic-pathologic correlation.
Diffuse Cystic Lung Disease: Consider Sjögren Syndrome in the Differential Diagnosis.
Autoimmune Myelofibrosis in Sjögren’s Syndrome: Report of a Case.
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren’s syndrome.
Utility of the EULAR Sjögren syndrome disease activity index in Japanese children: a retrospective multicenter cohort study.
[Inflammation in Dry Eye Disease – Information on Diagnostic Testing and Therapy Using the Scientific Online Information Platform OSCB-Berlin.org].
LAMP3 induces apoptosis and autoantigen release in Sjögren’s syndrome patients.
One year in review 2020: comorbidities, diagnosis and treatment of primary Sjögren’s syndrome.
Evaluation of soluble CD25 as a clinical and autoimmune biomarker in primary Sjögren’s syndrome.
An objective method of diagnosing hydroxychloroquine maculopathy.
Kikuchi-Fujimoto disease associated with primary Sjögren’s syndrome – literature review based on a case report.
Mesenchymal stem cell transplantation alleviates experimental Sjögren’s syndrome through IFN-β/IL-27 signaling axis.
Hypokalemic paralysis as an initial presentation of Sjogren syndrome.
Clinical Study of Jianfei Kangfu Cao in the Treatment of pSS-ILD
The BAFF / APRIL system as therapeutic target in multiple sclerosis.
Recent Advances in the Use of Exosomes in Sjögren’s Syndrome.
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren’s Syndrome
A Study on the Relevance of Glucose-6-Phosphate Dehydrogenase Level Screening in Patients with Rheumatic Diseases Prior to Initiating Treatment With Hydroxychloroquine.
Molecular Targeting of Immunosuppressants Using a Bifunctional Elastin-Like Polypeptide.
The effect of pilocarpine on dental caries in patients with primary Sjögren’s syndrome: a database prospective cohort study.
Clinical practice guidance for Sjögren’s syndrome in pediatric patients (2018) – summarized and updated.
Immune checkpoint inhibitors-induced autoimmunity: The impact of gender.
Transverse myelitis associated with primary biliary cirrhosis: clinical, laboratory, and neuroradiological features.
Infections in systemic autoimmune diseases.
The challenge of managing comorbidities: a case report of primary Sjogren’s syndrome in a patient with acute intermittent porphyria.
Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending.
Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors.
Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
Prognostic factors for primary Sjögren’s syndrome-associated interstitial lung diseases.
Characterization of a subset of patients with primary Sjögren’s syndrome initially presenting with C3 or C4 hypocomplementemia.
Connective tissue disease–associated interstitial lung disease: an underreported cause of interstitial lung disease in Sub-Saharan Africa.
Dental Implants in Sjögren Syndrome.
Connective Tissue Disease-Related Interstitial Lung Disease: Prevalence, Patterns, Predictors, Prognosis, and Treatment.
Refining myositis associated with primary Sjögren’s syndrome: data from the prospective cohort ASSESS.
Cricoarytenoid joint arthritis: a possible complication of dermatomyositis.
[Local and systemic light chain amyloidosis in patients with rheumatic diseases].
Acute severe sensory ganglionopathy in systemic lupus erythematous.

Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
Uveal Effusion Syndrome as the Initial Manifestation of Primary Sjögren’s Syndrome and Review of the Literature.
Nodular localized primary cutaneous amyloidosis and primary Sjögren’s syndrome.
The Valued Life Activities Scale (VLAs): linguistic validation, cultural adaptation and psychometric testing in people with rheumatic and musculoskeletal diseases in the UK.
[New directions of pharmacotherapy of immune – inflammatory rheumatic diseases].
An Innovative Online Qualitative Study to Explore the Symptom Experience of Patients with Primary Sjögren’s Syndrome.
Salivary Biomarkers and Their Application in the Diagnosis and Monitoring of the Most Common Oral Pathologies.
Hydroxychloroquine in rheumatic autoimmune disorders and beyond.
Corneal In Vivo Laser-Scanning Confocal Microscopy Findings in Dry Eye Patients with Sjögren’s Syndrome.
Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases Part 2.
A Complex Case of Polymyositis Overlapping With Hypothyroid Myopathy Without Underlying Autoimmune Thyroid Disorder.
Axial articular manifestations in primary Sjögren’s syndrome: Association with spondyloarthritis.
Multiple sclerosis and neuromyelitis optica after optic neuritis: A nationwide cohort study in Taiwan.
Drug-induced Bullous Pemphigoid and Lupus Erythematosus Occurring under Anti-TNF-α and IL-6 Therapy in a Patient with Rheumatoid Arthritis.
Lymphangioleiomyomatosis: A Case Report and Review of Clinical Features and Management.
Concomitant Sjögren’s Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis.
Pulmonary Involvement in a Mouse Model of Sjögren’s Syndrome Induced by STING Activation.
Focus on Effects of Chinese Medicine on Improving Anxiety-Depression and Quality of Life of Patients with Primary Sjögren’s Syndrome.
Inclusion-body myositis and primary Sjögren syndrome: mechanisms for shared etiologies.
Concurrent primary Sjögren’s syndrome and isolated ocular sarcoidosis presenting with bilateral corneal scarring and dry eye.
Characteristics of primary Sjögren’s syndrome related lymphocytic interstitial pneumonia.
The multifaceted functional role of DNA methylation in immune-mediated rheumatic diseases.
[Sjögren’s syndrome with juvenile onset].
A Case of Sjögren’s Syndrome as an Immune-related Adverse Event of Nivolumab Treatment for Gastric Cancer.
Spontaneous pregnancies in patients with at least one failed IVF cycle after the management of autoimmune disorders, hereditary thrombophilia, and methylation disorders.
Coexistence of Sarcoidosis and Sjögren’s syndrome with hypercalcemia and renal involvement: A case report and literature review.
Complicated case of Mycobacterium abscessus conjunctivitis in Sjögren’s syndrome.
A Tutorial on Saliva’s Role in Swallowing With a Focus on Sjögren’s Syndrome.
Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease
Articular and Peripheral Nervous System Involvement Are Linked to the Long-Term Outcome in Primary Sjögren’s Syndrome: The Relevance of Single Organ Manifestations Rather Than a Composite Score as Predictors.
Nephrological disorders and neurological involvement in pediatric primary Sjogren syndrome:a case report and review of literature.
Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren’s syndrome enrolled in a large observational US registry.
The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases
Peritoneal Carcinomatosis in an Adult With Sjögren’s Syndrome: A Diagnostic Dilemma Revealing a Rare Association With Primary Gastric Adenocarcinoma.
Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone.
Tirabrutinib: First Approval.
Total glucosides of paeony: A review of its phytochemistry, role in autoimmune diseases, and mechanisms of action.
Effectiveness of resistance exercise in functional fitness in women with primary Sjögren’s syndrome: randomized clinical trial.
Syndrome de Sjögren.
Hospital admission for blood collection for the preparation of autologous serum eye drops.
Congenital Complete Atrioventricular Heart Block in a Pregnant Woman with Sjögren Syndrome: Prenatal Care Follow-Up and the Challenge of Intrauterine Treatment.
Effective Treatment with Tocilizumab in a Rheumatoid Arthritis Patient Complicated with Human T-cell Leukemia Virus Type 1-associated Myelopathy: A Case Report.
[Mesenchymal stem cell treatment in autoimmune diseases].
Aberrant HLA-DR expression in the conjunctival epithelium after autologous serum treatment in patients with graft-versus-host disease or Sjögren’s syndrome.
Lack of Conventional Acinar Cells in Parotid Salivary Gland of Patient Taking an Anti-PD-L1 Immune Checkpoint Inhibitor.
Evaluation of the Efficacy and Safety of A Novel 0.05% Cyclosporin A Topical Nanoemulsion in Primary Sjögren’s Syndrome Dry Eye.
Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection.
Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.
Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjögren’s syndrome mouse model.
New Viral Facets in Oral Diseases: The EBV Paradox.
Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy.
Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy.
Achaete-Scute Homologue 2-Regulated Follicular Helper T Cells Promote Autoimmunity in a Murine Model for Sjögren Syndrome.
[Primary Sjögren’s Syndrome – News on Diagnostics and Therapy].
P2 Receptors as Therapeutic Targets in the Salivary Gland: From Physiology to Dysfunction.
Complementary therapy with traditional Chinese medicine for a patient with Sjögren’s syndrome: A case report.
Pulmonary Involvement in Sjögren Syndrome.
[The necessity and importance of standardized diagnosis and treatment of primary Sjögren’s syndrome].
[Recommendations of diagnosis and treatment of primary Sjögren’s syndrome in China].
Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome
Effects of Acupuncture on Sjögren’s Syndrome
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
Gene expression profiling of epithelium-associated FcRL4+ B cells in primary Sjögren’s syndrome reveals a pathogenic signature.
Shear wave elastography as a new method to identify parotid lymphoma in primary Sjögren Syndrome patients: an observational study.
Colchicine as possible treatment of non-cryoglobulinaemic vasculitis in Sjögren’s syndrome.
Dual function of miR-1248 links interferon induction and calcium signaling defects in Sjögren’s syndrome.
RESET Trial – Part 1 (Followed by Reset Trial – Part 2) – A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)
Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren’s syndrome.
Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy.
Recurrent aseptic meningitis: A rare clinical presentation of Sjogren’s syndrome.
Hyperkalemia in type 4 renal tubular acidosis associated with systemic lupus erythematosus.
[Targeted therapies for connective tissue diseases and vasculitis].
Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits.
Somatosensory profile of a patient with mixed connective tissue disease and Sjögren syndrome.
Severe anemia caused by hereditary hemorrhagic telangiectasia in a patient with Sjögren’s syndrome and primary biliary cirrhosis.
Hydroxychloroquine was associated with reduced risk of new-onset diabetes mellitus in patients with Sjögren syndrome.
HTLV-1 Infection and Rheumatic Diseases.
Stratifying Sjögren syndrome into symptom-based subgroups.
Elevated EPSTI1 promote B cell hyperactivation through NF-κB signalling in patients with primary Sjögren’s syndrome.
Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren’s syndrome to facilitate their concerted migration.
Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report.
Characteristics of diffuse large B-cell lymphoma in patients with primary Sjögren’s syndrome.
Intravenous immunoglobulin efficacy for primary Sjögren’s Syndrome associated small fiber neuropathy.
Characteristics and risk factors for pulmonary arterial hypertension associated with primary Sjögren’s syndrome: 15 new cases from a single center.
Association of Sjögren’s syndrome with myotonic dystrophy type 1.
Carnitine Palmitoyl Transferase Deficiency in a University Immunology Practice.
The Traditional Chinese Medicine Fufang Shatai Heji (STHJ) Enhances Immune Function in Cyclophosphamide-Treated Mice.
Sjögren’s Syndrome with Cerebral Venous Sinus Thrombosis: A Case Report and Literature Review.
Adolescent Sjogren’s syndrome presenting as psychosis: a case series.
Efficacy of dupilumab reveals therapeutic target for IgG4-related disease: simultaneous control of inflammation and fibrosis.
[Primary thymic mucosa-associated lymphoid tissue lymphoma: 7 clinical cases report and a review of the literature].
Antifibrotics in interstitial lung disease related to connective tissue diseases – a paradigm shift in treatment and outcome.
the Effect of Mixture of Natural Products As Salivary Substitutes in Treatment Of Xerostomia
Prevalence and clinical presentation of lymphoproliferative disorder in patients with primary Sjögren’s syndrome.
Toward better outcomes in Sjögren’s syndrome: The promise of a stratified medicine approach.
Emergence of rheumatoid arthritis following exposure to natalizumab.
Pulmozyme for Sjogren’s Associated Cough
Levocarnitine for Dry Eye in Sjogren’s Syndrome
A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome
Tolerance and Efficiency of an Intrabuccal Biological Film to Enhance Oral Dryness Sensation: The “PREDELFI” Clinical Pilot Study

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren’s Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis
Hyperglycemia and Salivary Gland Dysfunction in the Non-obese Diabetic Mouse: Caveats for Preclinical Studies in Sjögren’s Syndrome.
Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry Eye
Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren’s syndrome.
Overactive bladder and bladder pain syndrome/interstitial cystitis in primary Sjögren’s syndrome patients: A nationwide population-based study.
Sweet’s Syndrome Following Therapy with Hydroxychloroquine in a Patient Affected with Elderly-Onset Primary Sjogren’s Syndrome.
A 45-Year-Old Woman With Multiple Pulmonary Nodules and Sjögren Syndrome.
Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis.
Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
The value of MiR-146a and MiR-4484 expressions in the diagnosis of anti-SSA antibody positive Sjogren syndrome and the correlations with prognosis.
Prognostic factors for primary Sjögren’s syndrome-associated interstitial lung diseases.
Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases
Omalizumab for Lupus
Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren’s Syndrome
Secondary Sjögren syndrome: A case report using silver diamine fluoride and glass ionomer cement.
Rituximab-Bendamustine (R-Benda) in MALT lymphoma complicating primary Sjögren syndrome (pSS).
Increased risk of aortic aneurysm and dissection in patients with Sjögren’s syndrome: a nationwide population-based cohort study in Taiwan.
Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease
Associations between Antibiotics for Non-tuberculous Mycobacterial Infection and Incident Sjögren’s Syndrome: A Nationwide, Population-based Case-control Study.
Nivolumab in Treating Patients With Autoimmune Disorders or Advanced, Metastatic, or Unresectable Cancer
A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts